Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Kallikrein 1 (KLK1) (Middle Region) Peptid

KLK1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5511933

Kurzübersicht für Kallikrein 1 (KLK1) (Middle Region) Peptid (ABIN5511933)

Target

Kallikrein 1 (KLK1)

Spezies

Human

Quelle

  • 7
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    GFNMSLLENH TRQADEDYSH DLMLLRLTEP ADTITDAVKV VELPTEEPEV

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti- KLK1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Kallikrein 1 (KLK1)

    Hintergrund

    Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. This protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

    Alias Symbols: hK1, KLKR, Klk6

    Protein Size: 216

    Gen-ID

    3816

    NCBI Accession

    NM_002257, NP_002248
Sie sind hier:
Chat with us!